EITeam4
Hypertension &
Drug Dose Monitoring
1.000.000.000
Hypertension Patients
350.000.000
Overdosed
9.400.000
Deaths
10.000.000.000 €
Annual Savings
Problems
Patients
Doctors
Pharma Companies
Insurance Companies
Decision Makers
Over Dosage
Timing of Dosage
Reliable & 24/7 Monitoring
Reliability of Intake
It may be possible to reduce the number
and ...
Over Dosage
Timing of Dosage
Reliability of Intake
Reliable & 24/7 Monitoring
10 Billion
70 Million
ProblemsMarket(€)
Targ...
Over Dosage
Timing of Dosage
Reliability of Intake
“ The importance of adequate BP control over the
entire 24-hour period....
Over Dosage
Timing of Dosage
Reliability of Intake
More than 50% of all medicines are prescribed,
dispensed or sold inappr...
Over Dosage
Timing of Dosage
Ineffectivity of Drugs
Reliability of Intake
Half of all patients fail to take medicines
corr...
Clinical
Platform
1
2
Optimal Dose
Intake Monitoring
Blood Pressure
Heart Beat Rate
Drug Dose Info
Physical Exercise
Value...
Strategy
Clinics
End User
Care
Cardiologists
Publications
ISH
WHO
ASH
ESH
Strategy
Clinics
End User
Care
Cardiologists
Publications
ISH
WHO
ASH
ESH
Strategy
Insurance
Companies
(Joint Insurance)
Allianz Ae...
Clinics
End User
Care
Cardiologists
Publications
ISH
WHO
ASH
ESH
Strategy
Pharma
Companies
Bayer
Teva
Novartis
Merck & Co....
Clinics
End User
Care
Cardiologists
Publications
ISH
WHO
ASH
ESH
Strategy
Pharma
Companies
Bayer
Teva
Novartis
Merck & Co....
Clinics
End User
Care
GP
Insurance
Companies
(Joint Insurance)
Pharma
Companies
Cardiologists
End User
Prevention
Revenue ...
Clinics
End User
Care
GP
Insurance
Companies
(Joint Insurance)
Pharma
Companies
Cardiologists
End User
Prevention
1
Revenu...
Clinics
End User
Care
GP
Insurance
Companies
(Joint Insurance)
Pharma
Companies
Cardiologists
End User
Prevention
1
Revenu...
Clinics
End User
Care
GP
Insurance
Companies
(Joint Insurance)
Pharma
Companies
Cardiologists
End User
Prevention
1
3
Reve...
Go to India
1.2 billion
population
Go to India
1.2 billion
population
40 million
potential
customers
Go to India
1.2 billion
population
40 million
potential
customers
10% penetration
in 10 years
Go to India
1.2 billion
population
40 million
potential
customers
10% penetration
in 10 years
Go to India
Hypertension is a well-known...
Clinics
End User
Care
GP
Pharma
Companies
Cardiologists
1
3
Go to India
2
-30
65
160
255
350
Roadmap & Financials
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Profit Cumulative ...
Risk Analysis
0
25
50
75
100
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Technical Value Proposition Competitio...
Costs 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
R&D 3000000 2000000 1000000 1000000 500000 500000 250000 2500...
Nurse Visiting
Hospital Visiting
Clinical Cost
Data Security
Privacy
Drug Coverage
Side Effects
Connection
Report
Life Sty...
Hypertension and Drug Dose Monitoring - Business Plan
Upcoming SlideShare
Loading in...5
×

Hypertension and Drug Dose Monitoring - Business Plan

267

Published on

This is our final presentation of Summer School at High Tech Campus, Eindhoven, about our product DrugArt's business plan. We won the Best Entrepreneurial Team, at EIT ICT Labs Summer School, Wellbeing Innovation Camp 2013.

Published in: Business, Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
267
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Hypertension and Drug Dose Monitoring - Business Plan

  1. 1. EITeam4 Hypertension & Drug Dose Monitoring
  2. 2. 1.000.000.000 Hypertension Patients 350.000.000 Overdosed 9.400.000 Deaths 10.000.000.000 € Annual Savings Problems
  3. 3. Patients Doctors Pharma Companies Insurance Companies Decision Makers
  4. 4. Over Dosage Timing of Dosage Reliable & 24/7 Monitoring Reliability of Intake It may be possible to reduce the number and dosage of drugs. “ ESH/ESC Guidelines for the management of arterial hypertension, 2013 10 Billion ProblemsMarket(€) Decision Makers Targeted Problems Ineffectivity of Drugs
  5. 5. Over Dosage Timing of Dosage Reliability of Intake Reliable & 24/7 Monitoring 10 Billion 70 Million ProblemsMarket(€) Targeted Problems Decision Makers Ineffectivity of Drugs
  6. 6. Over Dosage Timing of Dosage Reliability of Intake “ The importance of adequate BP control over the entire 24-hour period. Journal of Managed Care Pharmacy, William B. White 2007 Reliable & 24/7 Monitoring 10 Billion 70 Million 1.5 Billion ProblemsMarket(€) Targeted Problems Decision Makers Ineffectivity of Drugs
  7. 7. Over Dosage Timing of Dosage Reliability of Intake More than 50% of all medicines are prescribed, dispensed or sold inappropriately May 2010, WHO “ 10 Billion 70 Million 1.5 Billion 5 Billion Reliable & 24/7 Monitoring ProblemsMarket(€) Targeted Problems Decision Makers Ineffectivity of Drugs
  8. 8. Over Dosage Timing of Dosage Ineffectivity of Drugs Reliability of Intake Half of all patients fail to take medicines correctly. May 2010, WHO “ 10 Billion 70 Million 1.5 Billion 5 Billion 2 Billion Reliable & 24/7 Monitoring ProblemsMarket(€) Targeted Problems Decision Makers
  9. 9. Clinical Platform 1 2 Optimal Dose Intake Monitoring Blood Pressure Heart Beat Rate Drug Dose Info Physical Exercise Value Proposition
  10. 10. Strategy
  11. 11. Clinics End User Care Cardiologists Publications ISH WHO ASH ESH Strategy
  12. 12. Clinics End User Care Cardiologists Publications ISH WHO ASH ESH Strategy Insurance Companies (Joint Insurance) Allianz Aetna AXA PPP
  13. 13. Clinics End User Care Cardiologists Publications ISH WHO ASH ESH Strategy Pharma Companies Bayer Teva Novartis Merck & Co. Insurance Companies (Joint Insurance) Allianz Aetna AXA PPP
  14. 14. Clinics End User Care Cardiologists Publications ISH WHO ASH ESH Strategy Pharma Companies Bayer Teva Novartis Merck & Co. Insurance Companies (Joint Insurance) Allianz Aetna AXA PPP GP End User Prevention
  15. 15. Clinics End User Care GP Insurance Companies (Joint Insurance) Pharma Companies Cardiologists End User Prevention Revenue Streams Worldwide
  16. 16. Clinics End User Care GP Insurance Companies (Joint Insurance) Pharma Companies Cardiologists End User Prevention 1 Revenue Streams Worldwide
  17. 17. Clinics End User Care GP Insurance Companies (Joint Insurance) Pharma Companies Cardiologists End User Prevention 1 Revenue Streams 2 Worldwide
  18. 18. Clinics End User Care GP Insurance Companies (Joint Insurance) Pharma Companies Cardiologists End User Prevention 1 3 Revenue Streams 2 Worldwide
  19. 19. Go to India
  20. 20. 1.2 billion population Go to India
  21. 21. 1.2 billion population 40 million potential customers Go to India
  22. 22. 1.2 billion population 40 million potential customers 10% penetration in 10 years Go to India
  23. 23. 1.2 billion population 40 million potential customers 10% penetration in 10 years Go to India Hypertension is a well-known chronic disease
  24. 24. Clinics End User Care GP Pharma Companies Cardiologists 1 3 Go to India 2
  25. 25. -30 65 160 255 350 Roadmap & Financials 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Operating Profit Cumulative Operating Profit million € 0 Cumulative Operating Profit with Pharmas ROI
  26. 26. Risk Analysis 0 25 50 75 100 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Technical Value Proposition Competition Go 2 Market
  27. 27. Costs 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 R&D 3000000 2000000 1000000 1000000 500000 500000 250000 250000 250000 250000 250000 Patenting 100000 100000 100000 0 0 0 0 0 0 0 0 Marketing & Market research 2000000 5000000 5000000 5000000 5000000 5000000 5000000 5000000 5000000 5000000 5000000 Platform running cost 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 Salaries 1000000 1000000 1000000 1000000 1000000 1000000 1000000 1000000 1000000 1000000 1000000 Logistics 50000 100000 100000 100000 100000 100000 100000 100000 100000 100000 100000 Misc Market Penetration Cost 5000000 10000000 10000000 10000000 25000000 25000000 10000000 10000000 10000000 10000000 10000000 Cost Breakdown
  28. 28. Nurse Visiting Hospital Visiting Clinical Cost Data Security Privacy Drug Coverage Side Effects Connection Report Life Style Service Cost Our Product Proteus Traditional high low Competition

×